These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28112248)

  • 1. Mechanistic interplay between ceramide and insulin resistance.
    Reali F; Morine MJ; Kahramanoğulları O; Raichur S; Schneider HC; Crowther D; Priami C
    Sci Rep; 2017 Jan; 7():41231. PubMed ID: 28112248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
    Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N
    Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C16:0-ceramide signals insulin resistance.
    Hla T; Kolesnick R
    Cell Metab; 2014 Nov; 20(5):703-705. PubMed ID: 25440051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of sphingolipid metabolism with calorie restriction enhances insulin action in skeletal muscle.
    Obanda DN; Yu Y; Wang ZQ; Cefalu WT
    J Nutr Biochem; 2015 Jul; 26(7):687-95. PubMed ID: 25771159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramide Synthase 5 Is Essential to Maintain C16:0-Ceramide Pools and Contributes to the Development of Diet-induced Obesity.
    Gosejacob D; Jäger PS; Vom Dorp K; Frejno M; Carstensen AC; Köhnke M; Degen J; Dörmann P; Hoch M
    J Biol Chem; 2016 Mar; 291(13):6989-7003. PubMed ID: 26853464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance induced by de novo pathway-generated C16-ceramide is associated with type 2 diabetes in an obese population.
    Chathoth S; Ismail MH; Alghamdi HM; Zakaria HM; Hassan KA; Alshomimi S; Vatte C; Cyrus C; Alsaif HS; Mostafa A; Shaaban H; Al Ali A
    Lipids Health Dis; 2022 Feb; 21(1):24. PubMed ID: 35184720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.
    Turpin SM; Nicholls HT; Willmes DM; Mourier A; Brodesser S; Wunderlich CM; Mauer J; Xu E; Hammerschmidt P; Brönneke HS; Trifunovic A; LoSasso G; Wunderlich FT; Kornfeld JW; Blüher M; Krönke M; Brüning JC
    Cell Metab; 2014 Oct; 20(4):678-86. PubMed ID: 25295788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats.
    Babenko NA; Kharchenko VS
    Biochemistry (Mosc); 2015 Jan; 80(1):104-12. PubMed ID: 25754045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sphingolipid salvage pathway in ceramide metabolism and signaling.
    Kitatani K; Idkowiak-Baldys J; Hannun YA
    Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceramide synthases: Reflections on the impact of Dr. Lina M. Obeid.
    Kim JL; Mestre B; Shin SH; Futerman AH
    Cell Signal; 2021 Jun; 82():109958. PubMed ID: 33607256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very long chain ceramides interfere with C16-ceramide-induced channel formation: A plausible mechanism for regulating the initiation of intrinsic apoptosis.
    Stiban J; Perera M
    Biochim Biophys Acta; 2015 Feb; 1848(2):561-7. PubMed ID: 25462172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CerS1-Derived C
    Turpin-Nolan SM; Hammerschmidt P; Chen W; Jais A; Timper K; Awazawa M; Brodesser S; Brüning JC
    Cell Rep; 2019 Jan; 26(1):1-10.e7. PubMed ID: 30605666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipid metabolism is a crucial determinant of cellular fate in nonstimulated proliferating Madin-Darby canine kidney (MDCK) cells.
    Nieto FL; Pescio LG; Favale NO; Adamo AM; Sterin-Speziale NB
    J Biol Chem; 2008 Sep; 283(37):25682-25691. PubMed ID: 18625703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered sphingolipid metabolism in human endometrial cancer.
    Knapp P; Baranowski M; Knapp M; Zabielski P; Błachnio-Zabielska AU; Górski J
    Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):62-6. PubMed ID: 20226264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity.
    Charytoniuk T; Sztolsztener K; Bielawiec P; Chabowski A; Konstantynowicz-Nowicka K; Harasim-Symbor E
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ceramide in regulating endoplasmic reticulum function.
    Zelnik ID; Ventura AE; Kim JL; Silva LC; Futerman AH
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jan; 1865(1):158489. PubMed ID: 31233888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of ceramide de novo synthesis in solid tissues changes sphingolipid levels in rat plasma, erythrocytes and platelets.
    Błachnio-Zabielska A; Baranowski M; Wójcik B; Górski J
    Adv Med Sci; 2016 Mar; 61(1):72-7. PubMed ID: 26521206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide.
    Yamaji T; Horie A; Tachida Y; Sakuma C; Suzuki Y; Kushi Y; Hanada K
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of glucose homeostasis and insulin action by ceramide acyl-chain length: A beneficial role for very long-chain sphingolipid species.
    Montgomery MK; Brown SH; Lim XY; Fiveash CE; Osborne B; Bentley NL; Braude JP; Mitchell TW; Coster AC; Don AS; Cooney GJ; Schmitz-Peiffer C; Turner N
    Biochim Biophys Acta; 2016 Nov; 1861(11):1828-1839. PubMed ID: 27591968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance.
    Kurek K; Mikłosz A; Łukaszuk B; Chabowski A; Górski J; Żendzian-Piotrowska M
    J Diabetes Res; 2015; 2015():154762. PubMed ID: 26380311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.